AMPICILLIN SODIUM /SULBACTAM SODIUM

AMPICILLIN SODIUM /SULBACTAM SODIUM C화학적 특성, 용도, 생산

Veterinary Drugs and Treatments

Ampicillin sodium/sulbactam sodium in a 2:1 ratio is effective when used parenterally for several types of infections caused by many beta-lactamase-producing bacterial strains of otherwise resistant E. coli, Pasturella spp., Staphylococcus spp., Klebsiella, and Proteus. Other aerobic bacteria commonly susceptible to this combination include Streptococcus, Listeria monocytogenes, Bacillus anthracis, Salmonella, Pasturella, and Acinetobacter. Anaerobic bacterial infections caused by Clostridium, Bacteroides, Fusobacterium, Peptostreptococcus or Propionibacterium may be effectively treated with ampicillin/sulbactam. Type I beta-lactamases that may be associated with Citrobacter, Enterobacter, Serratia and Pseudomonas are not generally inhibited by sulbactam or clavulanic acid. Ampicillin/sulbactam is ineffective against practically all strains of Pseudomonas aeruginosa.
In dogs and cats, ampicillin/sulbactam therapy may be considered when oral amoxicillin/clavulanate treatment is not viable (patient NPO, critically ill) or when large parenteral doses would be desirable (sepsis, pneumonia, other severe infections) for treating susceptible bacterial infections or prophylaxis.
Ampicillin/sulbactam has been used successfully to treat experimentally induced Klebsiella pneumonia in foals.

AMPICILLIN SODIUM /SULBACTAM SODIUM 준비 용품 및 원자재

원자재

준비 용품

AMPICILLIN SODIUM /SULBACTAM SODIUM 공급 업체

공급자	전화	이메일	국가	제품 수	이점
FRESENIUS KABI IPSUM SRL	--	alessandro.cescut@fresenius-kabi.com	Italy	17	58

AMPICILLIN SODIUM /SULBACTAM SODIUM 관련 검색: